cheqfx
Advertisement · 728×90
‹ All stocks
HLN

Haleon plc

HLN · NYSE · Healthcare
$8.75
▼ $8.75 (-0.51%)
$8.74 $8.90 $9.06 $9.22 $8.74 Sep 26 Sep 29 Oct 02
Day range
$8.71 – $8.80
Year range
$8.65 – $11.28
Open
$8.79
Previous close
—
Market cap
$38.51B
Volume (24h)
$6.5M
Volume (52w)
$56.73M
Performance
7D
▼ -4.63%
1M
▼ -11.76%
3M
▼ -10.03%
6M
▼ -11.84%
1Y
▼ -1.52%
YTD
▼ -12.55%
3Y
▲ 5.36%
5Y
▲ 19.79%
All-time
▲ 19.79%
Key statistics
P/E ratio
11.56
EPS (TTM)
$0.76
Dividend yield
2.26%
Dividend (TTM)
$0.20
Payout ratio
26.19%
Shares outstanding
4.4B
About Haleon plc

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Visit website
Country: United States of America
Advertisement · 300×250
More in Healthcare